uniQure (QURE) Gains from Investment Securities (2023 - 2026)
uniQure (QURE) posted quarterly Gains from Investment Securities of -$16.0 million for Q2 2026, down 808.52% year-over-year from $2.3 million in Q2 2025, and down 323.72% quarter-over-quarter from -$3.8 million in Q1 2026.
Powered by 
Analysis
uniQure (QURE) Gains from Investment Securities (2023 - 2026) Analysis & Trends
uniQure's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$16.0 million for Q2 2026.
- In Q2 2026, Gains from Investment Securities fell 808.52% year-over-year to -$16.0 million; the TTM figure through Jun 2026 stood at -$32.2 million (down 1082.47% YoY), while the FY2025 annual figure was -$12.4 million, down 582.72% from the prior year.
- Gains from Investment Securities for Q2 2026 stood at -$16.0 million, down from -$3.8 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $14.2 million in Q3 2023, with the low at -$18.1 million in Q4 2025.
- The 4-year median for Gains from Investment Securities is $226000.0 (2023), against an average of -$1.0 million.
- Peak annual rise in Gains from Investment Securities reached 1486.86% in 2025, while the deepest fall reached 8531.16% in 2025.
- uniQure's Gains from Investment Securities stood at $454000.0 in 2023, then plunged by 52.64% to $215000.0 in 2024, then sank by 8531.16% to -$18.1 million in 2025, then gained by 11.9% to -$16.0 million in 2026.
- Business Quant data shows QURE's Gains from Investment Securities at -$16.0 million in Q2 2026, -$3.8 million in Q1 2026, and -$18.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.97 Mn |
| Mar 31, 2026 | -3.77 Mn |
| Dec 31, 2025 | -18.13 Mn |
| Sep 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 215,000.00 |
| Sep 30, 2024 | -411,000.00 |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 454,000.00 |
| Sep 30, 2023 | 14.23 Mn |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 975,000.00 |